| HOME >> BIOLOGY >> TECHNOLOGY |
Bionovo, Inc.
(A Development Stage Company)
Condensed Balance Sheets
March 31, December 31,
2008 2007
(Unaudited) (Note 1)
ASSETS
Current assets:
Cash and cash equivalents $19,187,934 $ 28,472,485
Short-term investments 10,198,744 4,823,938
Receivables 19,942 285,899
Prepaid expenses and other current
assets 530,709 405,381
Total current assets 29,937,329 33,987,703
Property and equipment, net 4,040,105 3,900,248
Other assets and patent pending, net 733,445 277,220
Total assets $34,710,879 $38,165,171
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 206,799 $ 299,677
Accrued clinical and costs of other
studies 152,444 298,559
Accrued compensation and benefits 553,242 462,485
Current portion of lease obligation 928,252 706,710
Deferred revenue - -
Other current liabilities 540,922 949,200
Total current liabilities 2,381,659 2,716,631
Non-current portion of lease obligation 1,018,976 526,346
Non-current portion of deferred revenue
'/>"/>
| SOURCE Bionovo, Inc. Copyright©2008 PR Newswire. All rights reserved |